Novartis heart failure drug effective across patient groups Reuters India AMSTERDAM (Reuters) - An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug ... Novartis heart failure drug found to be effective across patient groups Novartis' serelaxin (RLX030) improved symptoms and mortality across multiple ... Novartis: RLX030 Improved Symptoms, Mortality In Heart Patients |
